Cancer Drug Prices Capped: Govt Sets 30% Trade Margin, Eyes up to 70% Cut in Costs

Cancer Medicines To Get Cheaper: Govt Caps Trade Margin at 30%, MRP May Drop up to 70% | 📰 LatestLY

The government is set to cap trade margins at 30% on expensive cancer drugs, including some patented medicines. MRPs could fall by up to 70%, and the measure is expected to take effect within 10 days. 📰 Cancer Medicines To Get Cheaper: Govt Caps Trade Margin at 30%, MRP May Drop up to 70%.

Cancer drug prices capped: Govt sets 30% trade margin, eyes up to 70% cut in costs

The Centre has capped trade margins at 30% for all non-scheduled anti-cancer drugs. The move follows Supreme Court scrutiny of steep mark-ups and is expected to lower treatment costs.

Cancer drug prices may fall as margins to be capped at 30%

Government targets high-cost cancer medicines, including some patented drugs, in a move that could cut MRPs by as much as 70%

Govt caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP

NEW DELHI: The government on Thursday decided to cap trade margins at 30% of the maximum retail price (MRP) for all non-scheduled anti-cancer drugs,

Big relief for cancer patients: Medicine prices may fall by up to 70% in India

Cancer patients in India could soon pay significantly less for certain expensive medicines as the Centre moves to cap trade margins on non-scheduled anti-cancer drugs at 30%. The government estimates that the decision could reduce some medicine prices by up to 70% and save patients around ₹2,500 crore annually.